文献速递糖尿病

1型糖尿病中施万细胞与神经纤维的结构改变及其与糖尿病多发性神经病变的关系

Structural changes in Schwann cells and nerve fibres in type 1 diabetes: relationship with diabetic polyneuropathy.
PubMed 文献 · Diabetologia · 2023-09-20

研究对比1型糖尿病无多发性神经病变、无痛性糖尿病多发性神经病变、痛性糖尿病多发性神经病变患者及健康对照的皮肤活检,用立体学方法定量施万细胞与神经纤维。结果显示皮肤施万细胞突起和神经纤维在糖尿病多发性神经病变患者中退变且相互依存,但与神经病变临床指标的关联较弱。

要点

  • 皮肤施万细胞突起和神经纤维在糖尿病多发性神经病变患者中退变,施万细胞胞体未见退变。
  • 糖尿病多发性神经病变患者中结构受损的痛觉施万细胞增多。
  • 皮肤施万细胞突起和神经纤维与神经病变临床指标呈弱相关。

核心结论

  • 糖尿病多发性神经病变患者皮肤施万细胞突起和神经纤维退变且相互依存,但施万细胞胞体未退变。
  • 糖尿病多发性神经病变患者中结构受损的痛觉施万细胞增多。
  • 皮肤施万细胞突起和神经纤维与神经病变临床指标弱相关,可能在1型糖尿病糖尿病多发性神经病变的病理生理中起部分作用。

研究设计与样本

  • 研究纳入1型糖尿病无多发性神经病变者25例、1型糖尿病合并无痛性糖尿病多发性神经病变者30例、1型糖尿病合并痛性糖尿病多发性神经病变者27例及健康对照25例。
  • 取3毫米皮肤活检,用相关抗体免疫染色显示施万细胞和神经纤维,采用立体学方法定量皮肤施万细胞和神经纤维表达。

主要发现

  • 未与神经纤维接触的痛觉施万细胞数量密度在组间存在差异(p=0.004)。
  • 与神经纤维接触的痛觉施万细胞数量密度、孤立或总表皮下施万细胞胞体数量密度在组间无差异。
  • 整体真皮施万细胞表达(真皮施万细胞面积分数和表皮下施万细胞突起密度)及周围神经纤维表达(表皮内神经纤维密度、真皮神经纤维面积分数和表皮下神经纤维密度)在组间存在差异(均p<0.05)。
  • 1型糖尿病合并无痛性糖尿病多发性神经病变组和痛性糖尿病多发性神经病变组与无糖尿病多发性神经病变组(健康对照和1型糖尿病组)相比均见显著差异(均p<0.05)。
  • 1型糖尿病合并无痛性糖尿病多发性神经病变组与痛性糖尿病多发性神经病变组之间、1型糖尿病组与健康对照组之间均无差异(均p>0.05)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Our aim was to investigate structural changes of cutaneous Schwann cells (SCs), including nociceptive Schwann cells (nSCs) and axons, in individuals with diabetic polyneuropathy. We also aimed to investigate the relationship between these changes and peripheral neuropathic symptoms in type 1 diabetes. METHODS: Skin biopsies (3 mm) taken from carefully phenotyped participants with type 1 diabetes without polyneuropathy (T1D, n=25), type 1 diabetes with painless diabetic polyneuropathy (T1DPN, n=30) and type 1 diabetes with painful diabetic polyneuropathy (P-T1DPN, n=27), and from healthy control individuals (n=25) were immunostained with relevant antibodies to visualise SCs and nerve fibres. Stereological methods were used to quantify the expression of cutaneous SCs and nerve fibres. RESULTS: There was a difference in the number density of nSCs not abutting to nerve fibres between the groups (p=0.004) but not in the number density of nSCs abutting to nerve fibres, nor in solitary or total subepidermal SC soma number density. The overall dermal SC expression (measured by dermal SC area fraction and subepidermal SC process density) and peripheral nerve fibre expression (measured by intraepidermal nerve fibre density, dermal nerve fibre area fraction and subepidermal nerve fibre density) differed between the groups (all p<0.05): significant differences were seen in participants with T1DPN and P-T1DPN compared with those without diabetic polyneuropathy (healthy control and T1D groups) (all p<0.05). No difference was found between participants in the T1DPN and P-T1DPN group, nor between participants in the T1D and healthy control group (all p>0.05). Correlational analysis showed that cutaneous SC processes and nerve fibres were highly associated, and they were weakly negatively correlated with different neuropathy measures. CONCLUSIONS/INTERPRETATION: Cutaneous SC processes and nerves, but not SC soma, are degenerated and interdependent in individuals with diabetic polyneuropathy. However, an increase in structurally damaged nSCs was seen in individuals with diabetic polyneuropathy. Furthermore, dermal SC processes and nerve fibres correlate weakly with clinical measures of neuropathy and may play a partial role in the pathophysiology of diabetic polyneuropathy in type 1 diabetes.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Hu X, Buhl CS, Sjogaard MB, et al. Structural changes in Schwann cells and nerve fibres in type 1 diabetes: relationship with diabetic polyneuropathy. Diabetologia. 2023. PMID: 37728731. doi:10.1007/s00125-023-06009-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。